| Clinical research in Turkey | Hamdi AKAN | 1–3 |
| Seropositivity rates of HBsAg, anti-HCV, anti-HIV and VDRL in blood donors in Eastern Turkey | İmdat DİLEK,CENGİZ DEMİR,Ali BAY,HAYRETTİN AKDENİZ,Ahmet Faik ÖNER | 4–7 |
| Late endocrine side effects in children with acute leukemia | Mustafa BÜYÜKAVCI,Nazan ÇETİNGÜL,Şükran DARCAN,Mehmet KANTAR,Kaan KAVAKLI | 8–13 |
| T102C polymorphism of the serotonin (5-HT) 2A receptor gene in Turkish children with cerebral infarct | Nebiye Buket DÖNMEZ,Serap TEBER,Gülhis DEDA,Nejat AKAR | 14–17 |
| Fibrinogen concentration: A marker of cardiovascular disorders in Nigerians | Olutayo Ifedayo AJAYI,Adekunle Ademola FAMODU,Efosa OVİASU | 18–22 |
| Synergistic effect of imatinib mesylate and fludarabine combination on Philadelphia chromosome-positive chronic myeloid leukemia cell lines | İnci ALACACIOĞLU, Bülent ÜNDAR, Fatih DEMİRKAN, G.Hayri ÖZSAN, Ali M ÖZCAN, Halil ATEŞ, Özden PİŞKİN | 23–27 |
| A case of Cauda Equina syndrome in a leukemic patient due to intrathecal methotrexate | Elif Birtaş ATEŞOĞLU,Tülin Fıratlı TUĞCULAR,Cafer ADIGÜZEL,Işık KAYGUSUZ,Figen NOYAN,Mustafa ÇETİNER,MURAT MAHMUT BAYIK | 28–31 |
| Intense myelofibrosis in a child: Unusual result of EBV-associated hemophagocytic lymphohistiocytosis | Bülent KARAPINAR,Deniz YILMAZ,Yeşim AYDINOK,Ebru TÜRKOĞLU,Mine HEKİMGİL,Kaan KAVAKLI | 32–35 |
| A further case of Hb J-Iran [beta77(EF1)His->Asp] in Muğla, Turkey | Nejat AKAR, Ece AKAR, Sibel ÖZDEMİR | 37–38 |